Recor Medical announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension
November 01, 2024 18:51 ET
|
Recor Medical
Palo Alto, CA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced U.S. Centers for...
Recor Medical Responds to the American Heart Association’s (AHA) Scientific Statement on Renal Denervation for the Treatment of Hypertension
August 19, 2024 09:00 ET
|
Recor Medical
Palo Alto, CA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) greatly appreciate the American...
CMS Approves Additional Payment for Recor Medical’s Paradise™ Ultrasound Renal Denervation System in Hospital Inpatient Cases
August 12, 2024 09:00 ET
|
Recor Medical
Palo Alto, CA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announced today that the Centers...
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension with Ultrasound Renal Denervation
July 25, 2024 10:00 ET
|
Recor Medical
Palo Alto, CA, July 25, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the first patients...
Recor Medical Champions Global Action on World Hypertension Day: Early Intervention and Continued Innovation Crucial in Tackling This Silent Killer Impacting Billions Worldwide
May 17, 2024 09:00 ET
|
Recor Medical
Palo Alto, CA, May 17, 2024 (GLOBE NEWSWIRE) -- Hypertension, or high blood pressure, affects nearly half of all Americans and more than one billion people worldwide. Hypertension is known as the...
Recor Medical Announces First Cases of Paradise Ultrasound Renal Denervation Therapy in the United Arab Emirates
April 18, 2024 11:00 ET
|
Recor Medical
Palo Alto, CA, April 18, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), announce the first commercial...
Renal Denervation Market: Patient-Centric Care, Set to Exceed USD 50.1 Billion by 2034 with 38.40% Growth – By PMI
February 19, 2024 19:30 ET
|
PMI
Covina, Feb. 19, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Renal Denervation Market size was valued at about USD 2.6 Billion in 2024 and expected to grow at CAGR of...
Renal Denervation Catheters Industry Pipeline Report, 2023 and Beyond - In-Depth Insights Into the Devices Under Development, Their Clinical Progress, and the Key Companies Shaping the Future
January 22, 2024 18:58 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Renal Denervation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies" report has been added to ...
Global Renal Denervation Technologies Strategic Research Report 2024
January 15, 2024 09:23 ET
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Renal Denervation Technologies - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Renal Denervation...
Global Renal Denervation Market Report 2023-2028: Funding Boosts Research and Market Expansion with United States Dominating
September 13, 2023 04:08 ET
|
Research and Markets
Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Renal Denervation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Technology, By Product, By...